Direct comparison of UDP-glucuronosyltransferase and cytochrome P450 activities in human liver microsomes, plated and suspended primary human hepatocytes from five liver donors

被引:7
|
作者
den Braver-Sewradj, Shalenie P. [1 ]
den Braver, Michiel W. [1 ]
Baze, Audrey [2 ,3 ]
Decorde, Joachim [4 ]
Fonsi, Massimiliano [4 ]
Bachellier, Philippe [3 ,5 ]
Vermeulen, Nico P. E. [1 ]
Commandeur, Jan N. M. [1 ]
Richert, Lysiane [2 ,6 ]
Vos, J. Chris [1 ]
机构
[1] Vrije Univ Amsterdam, Dept Chem & Pharmaceut Sci, AIMMS Div Mol Toxicol, O-2 Bldg,Boelelaan 1108, NL-1081 HZ Amsterdam, Netherlands
[2] Kaly Cell, 20A Rue Gen Leclerc, Plobsheim, France
[3] UNISTRA, 4 Rue Blaise Pascal, Strasbourg, France
[4] CiToxLAB France, BP 563, Evreux, France
[5] Hop Hautepierre, Ctr Chirurg Viscerale & Transplantat, F-67098 Strasbourg, France
[6] Univ Bourgogne Franche Comte, PEPITE EA4267, F-25000 Besancon, France
关键词
UDP-glucuronosyltransferases; Cytochrome P450; Primary human hepatocytes; Human liver microsomes; Reaction phenotyping; TANDEM MASS-SPECTROMETRY; CULTURED RAT HEPATOCYTES; IN-VITRO; GLUCURONIDE FORMATION; EFFLUX TRANSPORTERS; DRUG-INTERACTIONS; UGT ENZYMES; PHASE-I; METABOLISM; EXPRESSION;
D O I
10.1016/j.ejps.2017.07.032
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
UDP-glucuronosyltransferases (UGTs) and cytochrome P450s (CYPs) are the major enzymes involved in hepatic metabolism of drugs. Hepatic drug metabolism is commonly investigated using human liver microsomes (HLM) or primary human hepatocytes (PHH). We describe the development of a sensitive assay to phenotype activities of six major hepatic UGT isoforms (UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A9 and UGT2B7) in intact PHH by analysis of glucuronidation of selective probe substrates. The non-selective, general substrate 7-hydroxycoumarin was included for comparison. For each liver donor preparation (five donors) UGT activities in cryopreserved suspended and plated PHH were compared to HLM prepared from the same donors. Standard CYP reaction phenotyping of seven major isoforms was performed in parallel. For all donors, CYP- and UGT-isoforms activity profiles were comparable in PHH and HLM, indicating that reaction phenotyping with selective probe substrates in intact cells primarily reflects respective CYP or UGT activity. System-dependent effects on UGT and CYP isoform activity were still found. While UGT activity of UGT1A1 was equivalent in plated and suspended PHH, UGT1A3, UGT1A6 and UGT2B7 activity was higher in suspended PHH and UGT1A9 and UGT1A4 activity was higher in plated PHH. The well-known decrease in activity of most CYP isoforms in plated compared to suspended PHH was confirmed. Importantly, we found a significant loss in CYP2C19 and CYP2B6 in HLM, activity being lower than in intact cells. Taken together, these findings implicate that, dependent on the UGT or CYP isoforms involved in the metabolism of a given compound, the outcome of metabolic assays is strongly dependent on the choice of the in vitro system. The currently described UGT- and CYP-activity profiling method can be used as a standard assay in intact cells and can especially aid in reaction phenotyping of in vitro systems for which a limited number of cells are available.
引用
收藏
页码:96 / 110
页数:15
相关论文
共 50 条
  • [31] Sequential metabolism of 2,3,7-trichlorodibenzo-P-dioxin (2,3,7-triCDD) by cytochrome P450 and UDP-glucuronosyltransferase in human liver microsomes
    Kasai, N
    Sakaki, T
    Shinkyo, R
    Ikushiro, S
    Iyanagi, T
    Kamao, M
    Okano, T
    Ohta, M
    Inouye, K
    DRUG METABOLISM AND DISPOSITION, 2004, 32 (08) : 870 - 875
  • [32] No inhibition of cytochrome P450 activities in human liver microsomes by sulpiride, an antipsychotic drug
    Niwa, T
    Inoue, S
    Shiraga, T
    Takagi, A
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (01) : 188 - 191
  • [33] Effects of Eupatilin and Jaceosidin on Cytochrome P450 Enzyme Activities in Human Liver Microsomes
    Ji, Hye Young
    Kim, Sung Yeon
    Kim, Dong Kyun
    Jeong, Ji Hyun
    Lee, Hye Suk
    MOLECULES, 2010, 15 (09): : 6466 - 6475
  • [34] The inhibitory effects of amoxapine on cytochrome P450 enzyme activities in human liver microsomes
    Sakurai, E
    Iwase, M
    Kurata, N
    Nishimura, Y
    Yasuhara, H
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 130P - 130P
  • [35] INHIBITORY EFFECTS OF ASCHANTIN ON CYTOCHROME P450 ENZYME ACTIVITIES IN HUMAN LIVER MICROSOMES
    Choi, Wongu
    Kwon, Soon Sang
    Kong, Tae Yeon
    Kim, Ju-Hyun
    Cho, Yong Yeon
    Lee, Hye Suk
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S56 - S56
  • [36] Rapid determination of enzyme activities of recombinant human cytochromes P450, human liver microsomes and hepatocytes
    Ghosal, A
    Hapangama, N
    Yuan, Y
    Lu, XW
    Horne, D
    Patrick, JE
    Zbaida, S
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2003, 24 (09) : 375 - 384
  • [37] Inhibition of human drug-metabolising cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in vitro by uremic toxins
    Barnes, Kyra J.
    Rowland, Andrew
    Polasek, Thomas M.
    Miners, John O.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (09) : 1097 - 1106
  • [38] Inhibition of human drug-metabolising cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in vitro by uremic toxins
    Kyra J. Barnes
    Andrew Rowland
    Thomas M. Polasek
    John O. Miners
    European Journal of Clinical Pharmacology, 2014, 70 : 1097 - 1106
  • [39] Inhibitory Effects of Aschantin on Cytochrome P450 and Uridine 5′-diphospho-glucuronosyltransferase Enzyme Activities in Human Liver Microsomes
    Kwon, Soon-Sang
    Kim, Ju-Hyun
    Jeong, Hyeon-Uk
    Cho, Yong Yeon
    Oh, Sei-Ryang
    Lee, Hye Suk
    MOLECULES, 2016, 21 (05)
  • [40] Evaluation of P450 Inhibition and Induction by Artemisinin Antimalarials in Human Liver Microsomes and Primary Human Hepatocytes
    Xing, Jie
    Kirby, Brian J.
    Whittington, Dale
    Wan, Yakun
    Goodlett, David R.
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (09) : 1757 - 1764